Biotechnology - Companies & Stock Screener

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

YoY Change

Samsung Biologics Co.,Ltd.

207940.KS

Market Cap $65.69T

Dividends 0.0%

P/E Ratio 36.3

Revenue $1.49T -10.2%

Net Income $391B -31.9%

Profit Margin +26.2%

Employees 5.46K

View Stock

Celltrion, Inc.

068270.KS

Market Cap $48.81T

Dividends 0.3%

P/E Ratio 37.3

Revenue $1.58T +53.1%

Net Income $78.4B -76.3%

Profit Margin +5.0%

Employees 3.15K

View Stock

Alteogen Inc.

196170.KQ

Market Cap $12.27T

Dividends 0.2%

P/E Ratio 52.6

Revenue $120B +144.4%

Net Income $42.1B +88.6%

Profit Margin +35.2%

Employees 161

View Stock

Samsung Epis Holdings

0126Z0.KS

Market Cap $8.51T

Dividends 0.0%

P/E Ratio 96.7

Revenue $301M

Net Income $65.9M

Profit Margin +21.9%

Employees 9

View Stock

SK Biopharmaceuticals Co., Ltd.

326030.KS

Market Cap $6.88T

Dividends 0.0%

P/E Ratio 18.7

Revenue $258B +34.8%

Net Income $54.3B -26.7%

Profit Margin +21.0%

Employees 241

View Stock

HLB Co., Ltd.

028300.KQ

Market Cap $3.8T

Dividends 0.0%

P/E Ratio -23.9

Revenue $26B +17.5%

Net Income -$18.1B -75.3%

Profit Margin -69.5%

Employees 151

View Stock

SK bioscience Co.,Ltd.

302440.KS

Market Cap $3.06T

Dividends 0.0%

P/E Ratio -31.3

Revenue $182B +21.0%

Net Income $12B -50.9%

Profit Margin +6.6%

Employees 984

View Stock

LigaChem Biosciences Inc.

141080.KQ

Market Cap $2.29T

Dividends 0.0%

P/E Ratio -9.7

Revenue $14.5B -64.9%

Net Income -$55.9B +257.5%

Profit Margin -384.7%

Employees 180

View Stock

ABL Bio Inc.

298380.KQ

Market Cap $2.28T

Dividends 0.0%

P/E Ratio -28.2

Revenue $19.7B

Net Income -$14.7B

Profit Margin -74.7%

Employees 102

View Stock

Peptron, Inc.

087010.KQ

Market Cap $2.15T

Dividends 0.0%

P/E Ratio -105.0

Revenue $1.45B

Net Income -$7.71B

Profit Margin -533.7%

Employees 163

View Stock

Hugel, Inc.

145020.KQ

Market Cap $2.08T

Dividends 0.0%

P/E Ratio 17.8

Revenue $97.5B -7.9%

Net Income $4.72B -87.2%

Profit Margin +4.8%

Employees 629

View Stock

Voronoi, Inc.

310210.KQ

Market Cap $2.04T

Dividends 0.0%

P/E Ratio -27.2

Revenue $0.00

Net Income -$29B

Profit Margin

Employees 149

View Stock

D&D Pharmatech

347850.KQ

Market Cap $1.87T

Dividends 0.0%

P/E Ratio -80.8

Revenue $662M

Net Income -$8.27B

Profit Margin -1249.5%

Employees 22

View Stock

OliX Pharmaceuticals,Inc

226950.KQ

Market Cap $1.84T

Dividends 0.0%

P/E Ratio -134.1

Revenue $2.62B

Net Income -$11B

Profit Margin -418.6%

Employees 76

View Stock

Kolon TissueGene, Inc.

950160.KQ

Market Cap $1.03T

Dividends 0.0%

P/E Ratio -5.5

Revenue $829M

Net Income $50.3B

Profit Margin +6060.2%

Employees 58

View Stock

Bioneer Corporation

064550.KQ

Market Cap $899.49B

Dividends 0.0%

P/E Ratio -8.7

Revenue $96.2B +8.9%

Net Income -$1.94B +75.7%

Profit Margin -2.0%

Employees 608

View Stock

Bioneer Corp

064550.KS

Market Cap $899.49B

Dividends 0.0%

P/E Ratio -8.7

Revenue $96.2B +8.9%

Net Income -$1.94B +75.7%

Profit Margin -2.0%

Employees 608

View Stock

Chabiotech Co.,Ltd.

085660.KQ

Market Cap $693.77B

Dividends 0.0%

P/E Ratio 81.6

Revenue $316B

Net Income $29.3B

Profit Margin +9.2%

Employees 354

View Stock

Komipharm International Co., Ltd.

041960.KQ

Market Cap $604.51B

Dividends 0.0%

P/E Ratio -234.9

Revenue $16.7B

Net Income $618M

Profit Margin +3.7%

Employees 172

View Stock

Hyundai Bioscience Co., Ltd.

048410.KQ

Market Cap $595.43B

Dividends 0.0%

P/E Ratio -22.4

Revenue $520M

Net Income -$9.4B

Profit Margin -1807.1%

Employees 54

View Stock

Stock Screener

Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

Celltrion, Inc.

Celltrion, Inc.

Alteogen Inc.

Alteogen Inc.

Samsung Epis Holdings

Samsung Epis Holdings

SK Biopharmaceuticals Co., Ltd.

SK Biopharmaceuticals Co., Ltd.

HLB Co., Ltd.

HLB Co., Ltd.

SK bioscience Co.,Ltd.

SK bioscience Co.,Ltd.

LigaChem Biosciences Inc.

LigaChem Biosciences Inc.

ABL Bio Inc.

ABL Bio Inc.

Peptron, Inc.

Peptron, Inc.

Hugel, Inc.

Hugel, Inc.

Voronoi, Inc.

Voronoi, Inc.

D&D Pharmatech

D&D Pharmatech

OliX Pharmaceuticals,Inc

OliX Pharmaceuticals,Inc

Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

Bioneer Corporation

Bioneer Corporation

Bioneer Corp

Bioneer Corp

Chabiotech Co.,Ltd.

Chabiotech Co.,Ltd.

Komipharm International Co., Ltd.

Komipharm International Co., Ltd.

Hyundai Bioscience Co., Ltd.

Hyundai Bioscience Co., Ltd.

Cookie Settings